The study showed that in a mouse model of hormone-refractory prostate cancer, the combination of the bavituximab equivalent antibody 2aG4 and the chemotherapy drug docetaxel significantly decreased the
The combination of Tumor Targeted Superantigens (TTS) and Taxotere significantly improved anti-tumor activity compared to the respective mono therapy. Furthermore, combining TTS and Taxotere synergistically prolonged long-term survival
Virtual Radiologic expects the acquisition to contribute between $3 million and $3.5 million in annual revenue during 2008, and to contribute between $4 million and $4.5 million in
The FDA approval of Patanase nasal spray was based primarily on multiple clinical studies for the evaluation of safety, efficacy and onset of action. The results of these
Under the agreement, SynCo will fill and finish batches of OncoMed’s lead product, antibody OMP-21M18, for use in Phase I clinical trials. SynCo will fill and finish antibody
The study suggests that, while brostallicin is more effective in cells with normal p53 status, cells with abnormal or missing p53 are also killed when treated. P53 is
Following the effective date of termination of the co-promotion agreement there will be no continuing financial commitments for either company, and Santarus will no longer be obligated to
One of the studies is a Phase II clinical trial to assess the potential of the anti-IL-13 monoclonal antibody (MAb) in patients with uncontrolled asthma despite optimal treatment.
Treximet is said to be the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines pioneered
Judson Cooper, Lev’s chairman, said: “Our agreement to sell intermediate plasma products is consistent with our strategic plan to monetize this valuable asset for Lev and provides us
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.